Related Experiment Video
Updated: Jul 15, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
MRGPRX2 D184 Engagement by Food and Pollen Allergens: A Computational Hypothesis for IgE-Independent Mast-Cell
Yasuyuki Suzuki1,2,3, Shuang Liu4, Erika Takemasa4
1Department of Anaesthesiology, Saiseikai Matsuyama Hospital, Matsuyama, Japan, ysuzuki1978@gmail.com.
Introduction:
Some food and pollen allergic reactions, including anaphylaxis disproportionate to IgE titers, are not fully explained by IgE-mediated mechanisms. MRGPRX2, a polyspecific sensor of cationic ligands, mediates IgE-independent mast-cell degranulation and requires a salt bridge to aspartate D184. Whether protein allergens can adopt D184-engaging poses is unknown.
Methods:
Eleven peach, cedar pollen, peanut, birch, and yam allergens were docked against the experimental MRGPRX2 cryo-EM structure (PDB 7VV6) with HADDOCK3 under 3 protocols. Three agonists calibrated a D184 salt-bridge consistency threshold, four size-matched non-allergen proteins probed the determinants of engagement, and in silico mutagenesis tested D184 dependence.
Results:
Five allergens met a high-consistency threshold (≥2/3): Pru p 7, Cry j 7, Cry j 1, Pru p 3, and Ara h 6; Ara h 2 was moderate, and mature-chain Cry j 2 did not engage D184. Engagement was charge driven yet determined by a single accessible residue rather than net charge: HADDOCK score tracked the electrostatic term (ρ = 0.91) but not molecular weight (ρ = 0.27), the net-acidic Ara h 6 engaged through ARG4 while the net-neutral ubiquitin did not, and D184A abolished the salt bridge. Accordingly, size-matched non-allergen proteins presenting a surface lysine/arginine (ribonuclease A, carbonic anhydrase II) also formed genuine D184 salt bridges, whereas the acidic maltose-binding protein did not.
Conclusion:
Allergens presenting an accessible surface lysine or arginine can form the MRGPRX2 D184 salt bridge in agonist-like geometry, but engagement is governed by local cationic-residue accessibility rather than net charge or allergen identity - non-allergen proteins engage equally - so docking alone establishes neither specificity nor binding affinity, receptor activation, or clinical relevance. We propose a charge-based, exposure-gated hypothesis for experimental and clinical validation.
Related Concept Videos
Allergic Reactions
Allergic Drug Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cross-reactivity
Allergic Reactions: Anaphylaxis
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

